Ubs Group Ag Beyond Air, Inc. Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Beyond Air, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 152,062 shares of XAIR stock, worth $480,515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
152,062
Previous 39,653
283.48%
Holding current value
$480,515
Previous $10,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding XAIR
# of Institutions
44Shares Held
11.4MCall Options Held
49.6KPut Options Held
0-
Balyasny Asset Management LLC Chicago, IL3.33MShares$10.5 Million0.0% of portfolio
-
Lasry Marc New York, NY1.64MShares$5.18 Million9.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$4.59 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY937KShares$2.96 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA838KShares$2.65 Million0.0% of portfolio
About Beyond Air, Inc.
- Ticker XAIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 29,888,000
- Market Cap $94.4M
- Description
- Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...